side effects of glp-1 drugs Part 2 a 3-Part Series; Medications for Weight Loss GLP-1RA Essentials in Gastroenterology: Side

29,37 The biological basis of these differences remains poorly understood, and current evidence is largely derived from adult populations

In summary, these data suggest one of neuroprotective effects of GLP-1R agonists is inhibiting neuronal apoptosis

Patients who maintain their GLP-1 dose, eat a balanced diet, and incorporate regular movement see the most durable lipid improvements and weight loss maintenance

Patients with established cardiovascular disease should receive a pharmacological treatment intensification with an agent that has demonstrated benefit in cardiovascular safety studies: In patients with pre-existing atherosclerotic cardiovascular disease (ASCVD), a GLP-1 receptor agonist, or SGLT-2 inhibitor with characterized cardiovascular safety should be used

The oral format may appeal to beneficiaries who prefer not to use injections